Indian subsidiary of Merck Sharp and Dohme (MSD), a drug firm has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate ‘molnupiravir’, it said on Tuesday.
The drug is being studied for the treatment of Covid-19 with Indian firms Sun Pharma, Cipla, Dr Reddy’s, Emcure Pharma and Hetero Labs.
Molnupiravir is currently being studied in a Phase 3 trial for treatment of non-hospitalized patients with confirmed Covid-19, MSD India said in a statement.
Rice water, rich in inositol, antioxidants, vitamins, and minerals, protects hair from sunlight damage and…
Natural Remedies for Bloating: 8 Herbs and Supplements That Work Wonders for Your Gut Health…
Benefits of Oil Pulling: Stops Bad Breath, Keeps Gums Healthy, But Can't Replace Brushing Oil…
Spicy food – whether it’s a dash of chili in your curry, a spoonful of…
How To Identify Adulterated Wheat Flour? Try These 4 Easy Tests Wheat flour is a…
Reasons That Will Make You Eat Jaggery After Every Meal (Potential Health Benefits Inside) Jaggery,…